Hipro Biotechnology Corp, founded on September 29th, 2006, is a high-tech enterprise based on international advanced medical technologies and brilliant self-innovations to provide first-class products all over the world. Hipro focuses on R&D, manufacturing, marketing, and relevant services of Point-of-Care products. Hipro, with her reagent R&D Center at Silicon Valley, USA and instrument R&D Center at Freiburg, Germany, and production base in China - Hebei Province, has established branches in San Francisco, Freiburg， Beijing, Suzhou, Chengdu, Guangzhou, etc., and launched 3.69 acres industrial park project in China Medical City.
Hipro has a world-class high-capacity manufacturing facility （10000 sq.m.） with 1500 sq.m. current GMP plants and a strict quality control system. The quality system is NGSP, ISO 13485, and CE certified by TUV Rheinland.
Hipro is a leading specialist in the development and manufacturing of diagnostic system solutions of the highest quality, trusted by customers all over the world for over 15 years. The product portfolio comprises more than 50 parameters including Biochemistry, Nephelometry, Fluorescence, and Turbidimetric reagents for routine and special diagnostics including third-party calibrators and controls. The Hipro instrumentation product range covers automated immunoassay analyzers, semi-automated analyzers, and other POC instruments for patient-near testing.
As a professional POCT manufacturer, the sales network of Hipro covers the whole Chinese mainland, and throughout 68 countries: Switzerland, Netherlands, Germany, Austria, Greece, Iraq, Jordan, Lebanon, India, Indonesia, Egypt...